Hills Bank & Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-15,948
Closed -$1.58M 166
2019
Q3
$1.58M Sell
15,948
-8
-0.1% -$760 0.4% 58
2019
Q2
$1.48M Buy
15,956
+73
+0.5% +$6.93K 0.38% 60
2019
Q1
$1.5M Buy
15,883
+1,688
+12% +$148K 0.4% 61
2018
Q4
$909K Sell
14,195
-60
-0.4% -$4.43K 0.28% 74
2018
Q3
$1.28M Buy
14,255
+672
+5% +$59.4K 0.34% 68
2018
Q2
$1.08M Buy
13,583
+710
+6% +$59K 0.31% 68
2018
Q1
$1.15M Buy
12,873
+860
+7% +$82.6K 0.35% 64
2017
Q4
$1.25M Buy
12,013
+853
+8% +$96.2K 0.37% 59
2017
Q3
$1.63M Buy
11,160
+129
+1% +$17.6K 0.51% 46
2017
Q2
$1.43M Buy
11,031
+268
+2% +$32.8K 0.46% 49
2017
Q1
$1.34M Buy
10,763
+218
+2% +$26.1K 0.45% 49
2016
Q4
$1.22M Buy
10,545
+340
+3% +$37.9K 0.43% 55
2016
Q3
$1.07M Buy
10,205
+6,190
+154% +$670K 0.38% 60
2016
Q2
$396K Buy
4,015
+1,325
+49% +$137K 0.15% 94
2016
Q1
$269K Buy
+2,690
New +$277K 0.1% 109

Other funds holding CELG

Hills Bank & Trust's CELG Position: Q4 2019 in Review

Hills Bank & Trust sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 15,948 shares — an estimated $1.58M sold.

Hills Bank & Trust first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $1.63M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Hills Bank & Trust reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Hills Bank & Trust sold 15,948 Celgene Corp shares in Q4 2019, an estimated $1.58M.
  • Hills Bank & Trust first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • Hills Bank & Trust's Celgene Corp position peaked at $1.63M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Hills Bank & Trust's 13F filing for Q4 2019, filed 27 Jan 2020.